Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Santhera Starts To Think Big After Strong Launch Of DMD Drug

Sep 12 2024

• By Kevin Grogan

Eklund_Dario_1200 — Dario Eklund • Source: Santhera

Related Content

England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’

Mar 28 2024

Santhera Finds ‘Elegant Solution’ For Its Finances With Catalyst DMD Drug Deal

Jun 21 2023

Santhera Sets Out Launch Strategy For CHMP-Backed Duchenne Drug

Oct 13 2023

Related Companies

Santhera Pharmaceuticals

Catalyst Pharmaceuticals, Inc.

GENESIS Pharma S.A.

Additional Topics

Business Strategies Sales & Earnings Rare Diseases Commercial Deals BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window